Trial intelligence / Profile preview

Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder

NCT05013164Phase 2Completed

Sponsor
Nishtar Medical University
Start
Oct 2020
Primary completion
Mar 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of folinic acid in Autism Spectrum Disorder (ASD), sponsored by Nishtar Medical University. Started Oct 2020; status: completed.

02

Drugs

folinic acid
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT05013164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05013164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call